@article{ee9eea2a323149338de21371f3c7d02c,
title = "Editorial: Intestinal Dysbiosis in Inflammatory Diseases",
keywords = "dysbiosis, gut microbiota, gut permeability, inflammatory diseases, microbiota modulators",
author = "{de Oliveira}, {Gislane Lelis Vilela} and Cardoso, {Cristina Ribeiro de Barros} and Veena Taneja and Alessio Fasano",
note = "Funding Information: Conflict of Interest: AF holds stocks in Alba Therapeutics and receives financial support from Takeda Pharmaceuticals. VT has received financial support from Elysium Health and Evelo Biosciences.",
year = "2021",
month = jul,
day = "30",
doi = "10.3389/fimmu.2021.727485",
language = "English (US)",
volume = "12",
journal = "Frontiers in immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
}